Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
04/2007
04/24/2007US7208482 9-aminoacyl tetracycline compounds and methods of use thereof
04/24/2007CA2410852C 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinic receptor antagonists
04/19/2007WO2007043568A1 S1p3 receptor antagonist
04/19/2007WO2007042422A2 Process for the synthesis of amine ethers
04/19/2007WO2007041936A1 Alkyl alcohol piperazine derivative optical isomers and their salts and applications thereof
04/19/2007WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof
04/19/2007US20070088165 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
04/19/2007US20070088164 Combinatorial library approach to iminocyclitols with biological activity
04/19/2007US20070088052 Sulfonamide derivatives as 5ht7 receptor antagonists
04/19/2007US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
04/19/2007CA2626011A1 S1p3 receptor antagonist
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773797A2 Aromatic compounds
04/18/2007EP1773796A2 Oxopiperidine derivatives, preparation and therapeutic use thereof
04/18/2007EP1773779A1 Nicotinic receptor agonists for the treatment of inflammatory diseases
04/18/2007EP1773772A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
04/18/2007EP1773750A1 Chemical compounds
04/18/2007EP1773326A2 Mitotic kinesin inhibitors
04/18/2007EP1718627A4 Process for preparing optically active cetirizine or its salt
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007EP1276718B1 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
04/18/2007EP1028940B1 Process to produce oxazolidinones
04/18/2007CN1950754A Composition for removing a (photo)resist
04/18/2007CN1950393A Novel inhibitors of hepatitis c virus ns3 protease
04/18/2007CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
04/18/2007CN1950328A Phenyl indan derivatives
04/18/2007CN1948298A Dopamine D3 acceptor portion agonist and its application
04/18/2007CN1948297A Alkylol piperazine derivative optical isomer or its salt and its application
04/18/2007CN1948275A Verakanol Mannich alkali derivative, its preparation method and use
04/18/2007CN1948274A Verakanol derivative, its preparation method and use
04/18/2007CN1310892C Dithiocarbamate derivatives and their use as antibacterial agents
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators
04/17/2007US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205303 Substituted heterocyclic compounds
04/17/2007CA2407759C Substituted phenylacetamides and their use as glucokinase activators
04/17/2007CA2295792C A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
04/17/2007CA2250586C Meta-substituted phenylene sulphonamide derivatives
04/17/2007CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof
04/17/2007CA2175542C Anthraquinone hair dyes having a quaternary ammonium side chain
04/12/2007WO2007041307A1 Puleganic amides as insect repellants
04/12/2007WO2007040650A2 Apoptosis promoters
04/12/2007WO2007039809A1 Metabolites of 2- {3-[4-(5-fluoro-2-isopropoxy-phenyl)-piperazin-1-yl]-propyl} -5,6-dihydroxy-hexahydro-isoindole-1,3-dione
04/12/2007WO2007039170A1 Antagonists of topoisomerase activity and their use in inhibiting pathological conditions
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes
04/12/2007DE102005048552A1 Verfahren zur Herstellung von Ethylenaminen A process for the preparation of ethyleneamines
04/12/2007DE102005047458A1 Preparation of aminodiglycol and morpholine, useful as solvent and stabilizer for synthesizing e.g. synthetic resins, comprises reacting diethyleneglycol with ammonia in the presence of a transition metal heterogeneous catalyst
04/12/2007CA2623428A1 Puleganic amides as insect repellants
04/11/2007EP1772453A1 Process to produce Oxazolidinones
04/11/2007EP1771429A1 New benzoyl urea derivatives
04/11/2007EP1771428A1 Guanidine derivatives and therapeutic uses thereof
04/11/2007EP1771421A1 N-hydroxyamide derivatives and use thereof
04/11/2007EP1458689B1 Aryloxyphenyl and arylsulfanylphenyl derivatives
04/11/2007EP1351938B1 Phenyl derivatives
04/11/2007EP1307237B1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
04/11/2007CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
04/11/2007CN1946396A Medicine for prevention and/or treatment of ischemic circulatory disease
04/11/2007CN1944424A Aryl formyl piperazine compound and its preparing method and use in medicine production
04/11/2007CN1943786A Ester compound and its medicinal application
04/10/2007USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease
04/10/2007US7202269 GlyT2 modulators
04/10/2007US7202258 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
04/10/2007US7202254 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202242 Substituted 1 and 2-naphthol Mannich bases
04/10/2007CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/10/2007CA2204200C Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof
04/10/2007CA2127084C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-ht1a-antagonistic activity
04/05/2007WO2007038459A2 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
04/05/2007WO2007038116A1 Process to prepare amino acid derivatives
04/05/2007WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
04/05/2007WO2007036496A1 Method for preparing aminodiglycol (adg) and morpholine
04/05/2007WO2007016139A3 Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene
04/05/2007WO2007002884A3 4-fluoro-piperidine t-type calcium channel antagonists
04/05/2007WO2006076452A3 An exo-selective synthesis of himbacine analogs
04/05/2007US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
04/05/2007US20070078130 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases
04/05/2007US20070078120 Novel piperidine derivative
04/05/2007DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen
04/05/2007DE102005052376A1 Preparation of ethylene amine, useful as solvent and stabilizer for synthesizing e.g. synthetic resins, comprises reacting ethylene diamine in the presence of a transition metal heterogeneous catalyst
04/05/2007DE102005047464A1 Preparation of ethylene amine, useful as solvent and stabilizer for synthesizing e.g. synthetic resins, comprises reacting a monoethanol amine with ammonia in the presence of a transition metal heterogeneous catalyst
04/05/2007CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
04/05/2007CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
04/04/2007EP1768958A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
04/04/2007EP1768947A1 Process for the preparation of an (hetero) arylamine
04/04/2007EP1098642B1 Diamino-propanol-compounds for treating ischemia
04/04/2007CN1942551A New organic luminescent element
04/04/2007CN1942434A Indene derivatives and process for the preparation thereof
04/04/2007CN1942427A Indene derivatives and process for the preparation thereof
04/04/2007CN1942424A New photoinitiators
04/04/2007CN1308328C Novel process for the preparation of pyrazolopyrimidinones
04/04/2007CN1308292C Succinic acid semi-amides as anti-corrosives agents
04/04/2007CN1307971C Antimycotic nail varnish composition
04/03/2007US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/03/2007US7199241 Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
04/03/2007US7199158 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
04/03/2007CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 341